Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell–Dependent Adventitial Fibroblast Migration In Vitro
- 13 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (7) , 854-859
- https://doi.org/10.1161/01.cir.0000024113.26985.cc
Abstract
Background— Increased expression of osteopontin (OPN), fibroblast growth factors (FGFs), and their type-1 receptor (FGFR-1) is associated with neointima formation and atherosclerosis. This study tested the hypothesis that ligand activation of FGFR-1 stimulates OPN expression in rat aortic smooth muscle cells (RASMCs), explored the signaling pathway involved, and assessed the functional consequences of activating this pathway on adventitial fibroblast (AF) migration in vitro. Methods and Results— Exogenous FGF-1 stimulated expression of OPN mRNA and protein in RASMCs in vitro in a dose- and time-dependent manner. OPN mRNA induction by FGF-1 was completely inhibited by either actinomycin D or cycloheximide, selective inhibitors of RNA polymerase and protein synthesis, respectively. OPN mRNA induction by FGF-1 was attenuated by PD 166866, a highly selective and potent FGFR-1 tyrosine kinase inhibitor. Addition of either PP2 or PD98059, specific inhibitors of Src and mitogen-activated extracellular signal–regulated kinase (MEK)/mitogen-activated protein (MAP) kinases, respectively, attenuated FGF-1–stimulated OPN mRNA expression. FGF-1 treatment of RASMCs enhanced RASMC-conditioned medium-stimulated AF migration; this effect was inhibited by pretreatment of RASMCs with either PD166866 or PP2. Immunodepletion of OPN from RASMC-conditioned medium inhibited both basal and FGF-1–stimulated AF migration. Conclusions— This in vitro study provided a first indication that ligand-activated FGFR-1 plays a significant role in upregulation of OPN expression at the transcriptional level via signaling to Src/MEK/MAP kinases in RASMCs and that this pathway is functionally significant in mediating AF migration via stimulation of OPN expression.Keywords
This publication has 12 references indexed in Scilit:
- Signal transduction by fibroblast growth factor receptorsFrontiers in Bioscience-Landmark, 1999
- Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury1:Cardiovascular Research, 1997
- Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection.Journal of Clinical Investigation, 1994
- Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.Journal of Clinical Investigation, 1993
- Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.Journal of Clinical Investigation, 1993
- Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteriesCardiovascular Research, 1993
- Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivoNature, 1993
- Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.Proceedings of the National Academy of Sciences, 1992
- Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase.Molecular and Cellular Biology, 1990